Virtu Financial’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Virtu Financial’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,491	Closed	-$2K	–	2419
2023 Q1	$2K	Sell	10,491 -41,911	-80%	-$23.3K	﹤0.01%	1442
2022 Q4	$21K	Buy	+52,402	New	+$34.5K	﹤0.01%	1268
2021 Q3	–	Sell	-11,510	Closed	-$213K	–	2169
2021 Q2	$213K	Buy	+11,510	New	+$221K	0.02%	954

Virtu Financial's CDAK Position: Q2 2023 in Review

Virtu Financial sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 10,491 shares — an estimated $2K sold.

Virtu Financial first reported a position in CDAK in Q2 2021 and held it in 3 quarters. The position peaked at $213K in Q2 2021. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

Virtu Financial reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Virtu Financial sold 10,491 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $2K.
Virtu Financial first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Virtu Financial's Codiak BioSciences, Inc. Common Stock position peaked at $213K in Q2 2021.
1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.